MARS: The Why and How of It
The Multicenter ACL Revision Study (MARS Group) was assembled to address the issue of worse outcomes noted for revision ACL reconstructions noted by clinicians. It currently involves 83 surgeons at 52 sites which represents the most sites ever involved in a prospective orthopedic study. Greater than 1200 patients were enrolled, and 2-year follow-up has been completed at better than 80%. As described in this chapter, we have analyzed graft choice, meniscus, articular cartilage, surgical factors, rehabilitation factors, and their impact on outcome. The findings will allow us to counsel and treat patients more appropriately moving forward.
KeywordsGraft choice ACL Revision Multicenter study MARS
- 3.MARS Group (Wright RW corresponding author). Surgical predictors of clinical outcome after revision anterior cruciate ligament reconstruction. Am J Sports Med. 2017;45(11):2586–94.Google Scholar
- 11.Wright RW, Dunn WR, Amendola A, Andrish JT, Bergfeld J, Kaeding CC, et al. Risk of tearing the intact anterior cruciate ligament in the contralateral knee and rupturing the anterior cruciate ligament graft during the first 2 years after anterior cruciate ligament reconstruction: a prospective MOON cohort study. Am J Sports Med. 2007;35:1131–4.CrossRefGoogle Scholar